The deep problems of lack of good-quality pathology in many countries across the globe are being increasingly documented and solutions proposed.1 A key cause has been the “cloak of invisibility” that has surrounded the need for, and the needs of, such provision. This invisibility has applied particularly to the policy makers and funders of health care, resulting in lack of investment and allocation of resources to pathology. This invisibility is starting to change. The upcoming ninth, and final, volume of Disease Control Priorities 3 (DCP3) will contain a section called Cross Cutting Themes that for the first time will include a chapter on pathology and laboratory medicine.2,DCP3 is the third edition of the series Disease Control Priorities, which the World Bank, in collaboration with a number of...

Article PDF first page preview

Article PDF first page preview
Article PDF first page preview
You do not currently have access to this article.